In this article, important concepts in the molecular testing of non–small-cell lung cancer are highlighted.
Mufti N. Ahmad, MD, FACP
Advertisement
Articles by Mufti N. Ahmad, MD, FACP
Advertisement
Latest Updated Articles
Targeted Therapy for Mutation-Driven Metastatic Non–Small-Cell Lung Cancer: Considerations for ALK-Rearranged TumorsPublished: April 15th 2019 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Neoadjuvant Pembrolizumab/Radiotherapy Earns EU Approval in HNSCC Group
2
What is the Impact of the SHARON Trial on Pancreatic Cancer Research?
3
Pembrolizumab/Belzutifan Improves DFS in ccRCC Following Nephrectomy
4
ZEN-3694 Earns FDA Orphan Drug Designation in NUT Carcinoma
5
